A Message From The Creator

A Message From The Creator

Women’s Health: New Ovarian Cancer Screening Guidelines Highlight Lack Of Options For Women

Women’s Health: New Ovarian Cancer Screening Guidelines Highlight Lack Of Options For Women

Inspirational Woman Of The Day: Linda Soloman

Inspirational Woman Of The Day: Linda Soloman

Women’s News: 4 Things That May Affect The Way Your Boobs Look, According To Science (STUDY)

Women’s News: 4 Things That May Affect The Way Your Boobs Look, According To Science (STUDY)

Women’s News: 4 Things That May Affect The Way Your Boobs Look, According To Science (STUDY)

We all know that some changes to the way your breasts look are inevitable. Aging happens. But a new study has found that other factors may be at play when it comes to determining how your breasts look later in life.

A new study, published in the Aesthetic Surgery Journal found that at least four external factors (as opposed to internal factors like age or genetics) have a significant impact on a woman’s breasts. The study looked at the breasts of 161 pairs of identical twins, with an average age of 47.6 years old. Researchers took each woman’s medical and personal history, and then photographed her breasts and subjectively rated them based on 16 aesthetic measures, including perkiness, skin quality and areola size. (As lead researcher Hooman T. Soltanian of University Hospitals Case Medical Center and Case Western Reserve University School of Medicine, told ABC News, there’s “no objective measurement” of what makes breasts attractive. Thus these results are based on the researchers chosen criteria for attractiveness.)

Below are four factors — daily moisturizing, history of breast cancer, hormone replacement therapy and cigarette smoking — that the researchers found impacted the look of a woman’s breasts. While we all have much more to worry about than how our breasts look, it’s nice to know some of the things we may already do, like moisturizing regularly, actually make a difference.

Read More: http://www.huffingtonpost.com/2012/09/07/breast-attractiveness-4-things-affect-your-boobs-study_n_1866342.html?utm_hp_ref=women&ir=Women

 

Inspirational Woman Of The Day: Linda Soloman

Linda has over 20 years of extensive program leadership and business transformation experience focused on managing performance improvement. She is a leader in helping organizations design and execute large transformational programs that involve the implementation of new business processes, new organization structures and roles, and technology. In addition to her government consulting experience, Linda brings over 10 years of experience from a number of private industry sectors, including chemicals, oil and gas, and consumer products. In these industries, Linda led the implementation of supply chain and other operational best practice and technology solutions on a global basis.

Linda now serves as the Segment Leader for Deloitte’s Homeland Security segment. During the past six years Linda has worked exclusively serving the U.S. Department of Homeland Security (DHS) – NPPD Infrastructure Protection, ICE, FEMA, TSA and the Department Management Directorate. She leads the NPPD Infrastructure Protection (IP) engagement that is providing program management, budgeting and other mission support services to all of the IP divisions. She also leads the delivery of services to ICE in both critical mission areas such as the Office of State and Local Coordination which is responsible for the Department’s 287(g) program, and Federal Protective Service. During the past several years she partnered with ICE OCFO to assist them in addressing their material weaknesses. She and her team recently received the first DHS CFO Partnership Award for their accomplishments in supporting DHS ICE.

Before joining the Federal Practice, Ms. Solomon consulted to major manufacturing and energy companies around the world serving clients such as ExxonMobil, Shell, Monsanto, Ethyl, General Motors, and Honeywell. She has developed a strong reputation for managing large (e.g., multimillion dollar), complex, transformation and performance improvement programs typically involving the implementation of technology. She has managed teams around the world, including Canada, Brazil, the United Kingdom, Belgium, Singapore and Mexico. Before joining Deloitte Consulting in 1990, she worked for several years at Procter & Gamble in Cincinnati, Ohio.

Ms. Solomon graduated from New York University’s Stern School of Business with a MBA in Finance and was inducted into the Phi Beta Sigma Society for her academic achievements. She performed her undergraduate studies at the University of Pennsylvania where she graduated with a degree in computer mathematics and a minor in French. Throughout her career, Ms. Solomon has been the recipient of many awards, including the Women in Technology Leadership award.

Linda currently serves as a member of the Board of Directors for the Homeland Security and Business Defense Council and the Capital Area Food Bank where she leads the Strategic Development committee. In her free time, Ms. Solomon enjoys spending time with family and friends. She is passionate about giving back to the community and spends much of her time volunteering. She is an active member of Holy Comforter Episcopal Church and recently led the formation of an Adult Sunday School program. She plays tennis, runs in 10k and marathon races, and enjoys adventure travel.

Women’s Health: New Ovarian Cancer Screening Guidelines Highlight Lack Of Options For Women

Catherine Pearson

Catherine.Pearson@huffingtonpost.com

Not only is there still not a reliable routine test for ovarian cancer, the existing options may do more harm than good, according to a major government health panel.

The new U.S. Preventive Services Task Force recommendation, issued Monday, reaffirms its 2004 stance on ovarian cancer screening and highlights the lack of effective early detection options for

women.

“Screening for ovarian cancer is not a good use of a patient’s or a doctor’s time or resources,” Dr. Virginia Moyer, a member of the task force, told The Huffington Post. “It does not improve mortality, and no major organization recommends it.”

In 2012, more than 22,000 women in the U.S. will receive a new diagnosis for ovarian cancer, according to the American Cancer Society. The disease is relatively uncommon — a woman’s risk of developing ovarian cancer during her lifetime is about 1 in 71 — but it is dangerous. In the U.S., it is the fifth-leading cause of cancer death in women, behind cancer of the lung, breast, colon and rectum and pancreas.

“Ovarian cancer is worth screening for because it is very deadly,” said Dr. Stephanie Blank, an OB-GYN and associate professor with the NYU Langone Medical Center. Blank said outcomes would be improved if doctors could detect the disease earlier. However, the current screening methods are problematic, in part because they often lead to false positives, Blank explained.

In devising the new recommendations, the task force reviewed recent studies looking at the efficacy of the two most common tests used to screen for ovarian cancer: transvaginal ultrasound and the CA-125 blood test. The former, in which an ultrasound is used to look for masses in the ovaries, had generally been thought to be the more promising method for screening. The CA-125 test is used to check for levels of that protein in the blood, which are higher in women with ovarian cancer.

But neither reduces the number of deaths from ovarian cancer, the new USPSTF recommendation states, and there is “at least moderate certainty” that the harms outweigh the benefits.

It points to several studies that have found potential harms, such as false positives that have lead to major surgery, including removal of a woman’s ovary. One study found that, on average, for every one case of ovarian cancer detected, 33 women had surgery for a false positive.

Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial that began enrollment in 1993 and closed enrollment in 2001, involving more than 78,000 women, found that neither CA-125 or transvaginal ultrosonography reduced ovarian cancer mortality.

Neither the American Congress of Obstetricians and Gynecologists nor the American Cancer Society, nor most other major medical organizations, recommend routine screening healthy women for ovarian cancer.

Despite this, a survey conducted last February found that one in three physicians believed ovarian cancer screening is effective and many reported offering screening for low-risk women.

“Sometimes physicians are enthusiastic about cancer screening before the [scientific] evidence shows that the benefits outweigh the risks,” Dr. Laura-Mae Baldwin, an investigator on that study and a professor of family medicine with the University of Washington, said in a statement.

“It’s a killer disease. It would be really great to have a test,” Blank said, but there are roadblocks. One is that there are not many “precursors” to the disease that are easy to detect with a screening test, she said. For example, pap smears can be used to detect abnormal cervical cells that can develop into cervical cancer if untreated. As yet, doctors have no reliable way to look for abnormal ovarian cells that could turn cancerous. Ovarian cancer has sometimes been called the “silent killer” because it often goes undetected until the disease has progressed to a relatively advanced stage. Only 15 percent of patients with the disease are diagnosed early, when their chances of survival are highest.

Another difficulty in catching ovarian cancer early is that its symptoms aren’t specific to the disease. They include constipation, bloating, loss of appetite or feeling full more quickly after a meal and changes in urinary frequency.

Women with a family history of ovarian cancer have an increased risk of developing it, as do older women and women with inherited breast cancer genes or so-called“BRCA” mutations. The new USPSTF recommendations are for women with average risk — women with BRCA mutations should talk to their doctors about surveillance options.

Overall, experts say the findings highlight the pressing need for better screening and diagnostic tools for ovarian cancer, which has a lower relative five-year survival rate (46 percent) than cervical cancer (70 percent) and breast cancer (89 percent).

“Researchers need to keep working on finding a way to either prevent or diagnose this terrible disease very early,” Moyer, of the USPSTF, said.

Read More: http://www.huffingtonpost.com/2012/09/11/ovarian-cancer-screening_n_1871385.html?utm_hp_ref=women&ir=Women

A Message From The Creator

%d bloggers like this: